Repense is a communication campaign created to encourage debate and reflection on the medical use of marijuana in Brazil. The campaign began in March 2014 with the release of the short film ILEGAL (see the film) and a capture on the site of crowding Catarse. The donations of 362 people were used to produce this site, booklets, t-shirts, stickers and mugs. All the material was created to give visibility to the subject and to offer clear and reliable information on the subject. The therapeutic use of Cannabis sativa is a complex theme, but at the same time essential and urgent. We need to peel this pineapple. You can support the Repense campaign by posting this, enjoying and sharing our pages on Facebook and Youtube. And, more importantly, you can help change by talking to your friends and relatives about the medical potential of marijuana.
- Rethink – Repense is a communication campaign created to encourage debate and reflection on the medical use of marijuana in Brazil.
- Timeline – See the key moments in the history of the medical use of marijuana.
- Medicinal use in the world – Which countries use medical marijuana? How?
- Scientific evidences – Access research on the therapeutic use of marijuana.
|Multiple sclerosis / spasticity||Effect of dronabinol on the progression of progressive multiple sclerosis: a randomized, placebo-controlled study.||Zajicek J, Ball S, Wright D, Vickery J, Nunn A, Miller D, Cano MG, McManus D, Mallik S, Hobart J||2013||Dronabinol (synthetic THC)||Used for 36 months, THC had no effect on disease progression compared to placebo.|
|Multiple sclerosis / spasticity||Cannabis smoked for spasticity in multiple sclerosis: a randomized, placebo-controlled study.||Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B.||2012||Cannabis in natura||Smoking cannabis was superior to placebo in reducing spasticity and pain.|
|Chemo Pain||A double-blind, placebo-controlled, cross-over trial using oral cannabinoid extract spray for the treatment of cancer-induced neuropathic pain.||Lynch ME, Cesar-Rittenberg P, Hohmann AG.||2013||Marijuana Extract||Among the five patients, there was a tendency to respond to treatment with cannabis|
|Nausea and vomiting of cancer chemotherapy||Preliminary study of the efficacy and safety of standard oral extract of Cannabis in nausea and vomiting induced by chemotherapy.||Duran M, Pérez E, Abanades S, Vidal X, Saura C, Majem M, Arriola E, Rabanal M, Pastor A, Farré M, Rams N, Laporte JR, Capellà D.||2010||Marijuana Extract||Cannabis was superior to placebo in reducing nausea and vomiting in patients refractory to other medications.|
|Epilepsy||Chronic cannabidiol administration for healthy volunteers and epileptic patients.||Cunha JM, Carlini EA, Pereira AE, Ramos OL, Pimentel C, Gagliardi R, Sanvito WL, Lander N, Mechoulam R||1980||Canabidiol||Of the eight patients tested, four became seizure free during the study and three showed partial improvement.|
|Epilepsy||Parents’ report on the use of cannabis extract enriched with cannabidiol in the treatment of treatment-resistant epilepsy.||Porter BE, Jacobson C||2013||Canabidiol||84% of the 19 patients evaluated showed improvements in the frequency of seizures.|
FREQUENTLY ASKED QUESTIONS
How to import?
The production, purchase and sale of marijuana are prohibited in Brazil, but current legislation provides that the State may authorize the cultivation for medicinal purposes. Despite this, the National Health Surveillance Agency (Anvisa) does not have a regulation that guides the citizens on how to obtain this authorization. Therefore, the only legal alternative to obtaining marijuana or derivatives for medical use is to import these products.
Currently, it is possible to purchase medical marijuana from abroad by making an “exceptional import request for personal use”. Check below the instructions and document templates needed to make this request, provided by Anvisa:
The importation of medicines subject to special control without registration in the country by natural person is possible by means of exceptional request of importation for personal use. If this formal request is made, Anvisa will analyze the possibility of authorizing the acquisition exceptionally. To initiate an exceptional import request for personal use, a request must be sent to the Office of the Chief Executive Officer (GADIP):
Office of the Chief Executive Officer (GADIP)
National Agency for Sanitary Surveillance (ANVISA)
Industry and Supply Sector
Section 5, Special Area 57
Brasília, Federal District
In this request, it is important to present the following original documents:
Medical prescription containing the name of the patient and the medication, dosage, quantity required, time of treatment, date, signature and doctor’s stamp (with CRM).
Medical report containing CID and name of the pathology, case description, justification for the use of a drug not registered in Brazil, in comparison with the existing therapeutic alternatives registered by Anvisa.
Term of responsibility signed by the doctor and patient / legal guardian.
Request for the exceptional importation of medicines subject to special control: completed and signed by the patient or legal guardian.
To expedite the process, an electronic copy of this request must be sent to the following e-mails: firstname.lastname@example.org; email@example.com and firstname.lastname@example.org.
Upon receipt of the documentation, the detailed clarifications will be provided for processing the process with Anvisa, at which time additional information will be requested. Issues related to taxation and customs clearance must be verified with the IRS. The interested party must pay attention to the available import modalities and their respective taxes or tax exemptions, as the case may be.
What is vaporizing?
Inhale the vapors produced by heating the grass, at a lower temperature than the combustion, with the help of vaporizing equipment. This procedure releases cannabinoids of medicinal effect, without producing smoke and its toxic components.
What are the side effects?
Products with THC or synthetic substances that mimic their effects can cause marijuana-like effects: pleasure and relaxation, dizziness, loss of motor coordination, sleep, difficulty concentrating, and increased appetite. Symptoms are temporary and may or may not appear depending on the dose and sensitivity of the patient. In the case of Sativex , only 12% of patients give up medication because of side effects.
Regular use of marijuana can lead to dependence, respiratory and memory problems, and its chronic use is associated with a higher incidence of schizophrenia. The contraindications should be analyzed according to the case of each patient. Talk to your doctor.